Lightcast profiled by Illumina Ventures for their March Portfolio Company Spotlight

We're honored to count Illumina Ventures among our funding partners, and were happy to chat with them about our technology for this Portfolio Company Spotlight.

This article takes a deep dive into the workings of the Lightcast platform and its potential to transform and accelerate drug discovery workflows. As Illumina Ventures Partner Wouter Meuleman said: 

“Lightcast has created a new tool that will soon help labs investigate single-cell, functional biology, something that has never been done before. Current approaches generally query the molecular drivers in cells, but investigators can only infer what they mean. These micro assays allow scientists to witness how cells actually respond in real-time.” 

Read the full feature on the Illumina Ventures website.

‍